EU pharmaceutical regulation: The politics of policy-making

EU pharmaceutical regulation: The politics of policy-making

by Govin Permanand

Hardcover

$115.00
Eligible for FREE SHIPPING
  • Want it by Wednesday, October 17?   Order by 12:00 PM Eastern and choose Expedited Shipping at checkout.

Overview

EU pharmaceutical regulation: The politics of policy-making by Govin Permanand

This book provides an analysis of European Union pharmaceutical regulation from a policy-making perspective. The focus is on how the often conflicting agendas of the pharmaceutical industry, the EU member states, the European Commission, and consumer interests are reconciled within the context of regulatory outcomes having to serve public health, healthcare and industrial policy needs within the single market.

Breaking with more traditional approaches which stress the economic determinants of pharmaceutical policy, different strands of public policy analysis, regulatory and European integration and policy-making theories are invoked in developing a new conceptual approach to frame the analysis. In-depth case-studies in three key policy areas: patent protection, market authorisation, and pricing and reimbursement, provide substantive support.

In providing a unique perspective on how and why EU pharmaceutical policy is made, the book will be of interest to academics, students and policy-practitioners interested in EU policy-making, regulation and public policy analysis.

Product Details

ISBN-13: 9780719072727
Publisher: Manchester University Press
Publication date: 09/05/2006
Series: European Policy Studies Series
Pages: 264
Product dimensions: 9.30(w) x 6.40(h) x 1.10(d)

About the Author

Govin Permanand is Research Fellow at LSE Health and Social Care, London School of Economics and Political Science

Table of Contents

1. EU pharmaceutical policy: towards an understanding of the issues

2. Regulating the European medicines sector

3. Theorising the development of community competence in pharmaceuticals

4. Networks and the 'politics of policy'

5. 'Client politics': the Supplementary Protection Certificate

6. 'Entrepreneurial politics': the European Medicines Agency

7. 'Majoritarian politics': the pricing and reimbursement of medicines in the EU

8. Conclusions

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews